Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

By sjmartinez • April 25, 2024

Ghafari-Saravi A, Haussmann A, Wu J, Cheng K. Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod. JAAD Case Rep. 2024 Mar 15;47:68-71. doi: 10.1016/j.jdcr.2024.03.005. PMID: 38659474; PMCID: PMC11039778.

Tags: autoimmune disease, Dermatology, efgartigimod, Fellow, immunomodulatory therapy, P-ANCA vasculitis, perinuclear anti-neutrophil cytoplasmic antibodies, Publications, Resident, Rheumatology, Vasculitis

Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African American Women

Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]

Treatment of Solar Lentigines: A Systematic Review of Clinical Trials

Mardani G, Nasiri MJ, Namazi N, Farshchian M, Abdollahimajd F. Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. J Cosmet Dermatol. 2025 Apr;24(4):e70133.[...]

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M. Deucravacitinib: Laboratory Parameters[...]